Kedrion Launches QIVIGY® in the U.S. with Nationwide Distribution
- On March 25, 2026
Kedrion has activated a robust nationwide U.S. distribution network to support the commercial availability of QIVIGY, its FDA approved 10% Intravenous Immunoglobulin (IVIG) therapy.
Read More